|
Caduet.(New & Approved)
Publication: Skin & Allergy News Publication Date: 01-APR-04 Author: Mechcatie, Elizabeth
|
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2004 International Medical News Group
(amlodipine besylate and atorvastatin, Pfizer)
A combined formulation of the long-acting calcium channel blocker Norvasc (amlodipine) with the lipid-lowering drug Lipitor (atorvastatin), for patients for whom treatment with both drugs is appropriate. Norvasc is indicated for hypertension, chronic stable angina, and vasospastic angina; Lipitor's indications include primary hypercholesterolemia and elevated...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Skin & Allergy News |
Avastin.(New & Approved)
April 01, 2004
|
Topical solutions for breast Ca radiation dermatitis: avoid any contai...
April 01, 2004
|
Health care spending, 2002.(Data Watch)(Brief Article)(Illustration)
April 01, 2004
|
Etanercept success spurs search for other targets: psoriatic arthritis...
April 01, 2004
|
Bosentan healed digital ulcers in scleroderma: endotheline receptor bl...
April 01, 2004
|
|
| Find companies classified under Pharmaceutical preparations |
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
